Prafnosbart
帕拉索拜单抗
Report date: 2023/05/11 13:30:53
Base Information
Drug NamePrafnosbart
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co LtdSaitama Medical University
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A